DROPA gel à la consoude tb 100 g

7680607200015 CH-60720 M02AX10 07.10.4.

Reimbursement limitations:

DARZALEX.01b

DARZALEX en monothérapie (4L+) (avec modèle de prix): Uniquement en monothérapie pour le traitement des …

DROPA gel à la consoude tb 100 g
DROPA gel à la consoude tb 100 g
DROPA gel à la consoude tb 100 g
1 / 3
google

Details

Product number
6072001
CPT
-
Packaging group
100
Unit
g
Composition
symphyti radicis recentis extractum ethanolicum liquidum (Symphytum officinale L., radix) 350 mg DER: 1:3-4 Auszugsmittel ethanolum 52% (m/m), hyperici herbae recentis extractum ethanolicum liquidum (Hypericum perforatum L., herba) 50 mg DER: 1:1.5-2.5 Auszugsmittel ethanolum 86 % (m/m), calendulae herbae recentis extractum ethanolicum liquidum (Calendula officinalis L., herba) 50 mg DER: 1:1.5-2.5 Auszugsmittel ethanolum 86 % (m/m), echinaceae purpureae herbae recentis extractum ethanolicum liquidum (Echinacea purpurea L., herba) 25 mg DER: 1:1.5-2.5 Auszugsmittel ethanolum 86 % (m/m), menthae piperitae recentis extractum ethanolicum liquidum (Mentha x piperita L., herba) 25 mg DER: 1:1.5-2.5 Auszugsmittel ethanolum 86 % (m/m), ethanolum 96 per centum, aqua purificata, carbomerum 980, diisopropanolaminum, ad gelatum 1 g, corresp. ethanolum 330 mg.

Articles (1)

Dropa Wallwurzgel, Gel
Gel
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/09/2022
Patient information leaflet
Français
26/09/2022
Patient information leaflet
Italien
26/09/2022

Detailed composition

Substance Quantity Type Category
symphyti radicis recentis extractum ethanolicum liquidum
350.0 MG Substance Wirkstoff (Principe actif)
hyperici herbae recentis extractum ethanolicum liquidum
50.0 MG Substance Wirkstoff (Principe actif)
calendulae herbae recentis extractum ethanolicum liquidum
50.0 MG Substance Wirkstoff (Principe actif)
echinaceae purpureae herbae recentis extractum ethanolicum liquidum
25.0 MG Substance Wirkstoff (Principe actif)
menthae piperitae recentis extractum ethanolicum liquidum
25.0 MG Substance Wirkstoff (Principe actif)
ethanolum 96 per centum
- Substance HBESI
aqua purificata
- Substance HNIDK
carbomerum 980
- Substance HNIDK
diisopropanolaminum
- Substance HNIDK
ethanolum
330.0 MG Substance HBESI

Authorization holder

DR. BÄHLER DROPA AG

8045 Zürich

Authorization information

Swissmedic authorization number
60720
Drug name
Dropa Wallwurzgel, Gel
Galenic form
GELK
ATC Code
M02AX10
Authorization status
Z
Authorization category
Category C
Dispensation category
D
First authorization
16/10/2009
Authorization expiration date
31/12/9999
IT number
07.10.4.
Domain
Human medicine
Field of application
Bei stumpfen Verletzungen und zur unterstützenden Behandlung bei rheumatischen Beschwerden

Packaging details

Description (FR)
DROPA gel à la consoude tb 100 g
Description (DE)
DROPA Wallwurzgel Tb 100 g
Market launch
16/10/2009
Narcotic (BTM)
No
Buy us a coffee Explore the data